Kiniksa Pharmaceuticals International, plc (KNSA) operating KPIs
KNSANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 27, 2026Score 14/30692% above fair value
$92.24−5.32 (-5.45%)
Close on Oct 30, 2026Market cap $14.39BP/E 95.1Yield –
KPIs
Operating metrics that drive Kiniksa Pharmaceuticals International's business
Coming soon
This tab will track the numbers specific to Kiniksa Pharmaceuticals International's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.